Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control study.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 26415892)

Published in Cancer Causes Control on September 28, 2015

Authors

Danny V Colombara1, Lisa E Manhart2, Joseph J Carter3, Stephen E Hawes2, Noel S Weiss2,3, James P Hughes4, Matt J Barnett3, Gary E Goodman3, Jennifer S Smith5, You-Lin Qiao6, Denise A Galloway3

Author Affiliations

1: Institute for Health Metrics and Evaluation, Seattle, WA; and dvc2@uw.edu.
2: Department of Epidemiology, School of Public Health, University of Washington, 1959 NE Pacific Street, Health Sciences Building F-250, Box 357236, Seattle, WA, 98195-7236, USA.
3: Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., P.O. Box 19024, Seattle, WA, 98109-1024, USA.
4: Department of Biostatistics, School of Public Health, University of Washington, F-600, Health Sciences Building, Box 357232, Seattle, WA, 98195-7232, USA.
5: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, 135 Dauer Drive, 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC, 27599-7435, USA.
6: Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, 17 South Pan Jia Yuan Lane, Chaoyang Dist., P. O. Box 2258, Beijing, 100021, People's Republic of China.

Articles cited by this

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science (2008) 16.60

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06

Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog (2007) 8.01

Identification of a third human polyomavirus. J Virol (2007) 7.06

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst (1996) 5.63

A simple method of sample size calculation for linear and logistic regression. Stat Med (1998) 4.74

Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem (2005) 4.18

Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe (2010) 3.78

Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog (2010) 3.15

Suppression of non-specific binding in serological Luminex assays. J Immunol Methods (2005) 2.96

Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer (2009) 2.77

Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68

The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst (2004) 2.26

Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst (2009) 2.22

Incidence of human papilloma virus in lung cancer. Lung Cancer (2008) 2.16

A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods (2001) 2.15

HPV and lung cancer risk: a meta-analysis. J Clin Virol (2014) 2.12

Identification of MW polyomavirus, a novel polyomavirus in human stool. J Virol (2012) 2.10

Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N Engl J Med (2012) 2.08

A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol (2011) 2.03

Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing. Virology (2012) 1.75

Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst (2011) 1.59

Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors. Am J Surg Pathol (2009) 1.56

The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res (1994) 1.49

Discovery of a novel polyomavirus in acute diarrheal samples from children. PLoS One (2012) 1.48

Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog (2008) 1.44

Detection of Merkel cell polyomavirus with a tumour-specific signature in non-small cell lung cancer. Br J Cancer (2013) 1.41

Cancers attributable to human papillomavirus infection. Sex Health (2010) 1.33

Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol (2012) 1.27

Identification of a novel human polyomavirus in organs of the gastrointestinal tract. PLoS One (2013) 1.26

Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis. Carcinogenesis (2009) 1.19

Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J Gen Virol (2010) 1.16

Cancer and viral infections in immunocompromised individuals. Int J Cancer (2009) 1.12

Comments on "HPV and lung cancer risk: a meta-analysis" [Zhai et al., J. Clin. Virol. (in press)]. J Clin Virol (2014) 1.11

Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J Gen Virol (1992) 1.06

Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. Eur J Cancer (2009) 1.02

Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy. J Gen Virol (2009) 1.01

Detection of human papillomavirus in lung cancer: systematic review and meta-analysis. Anticancer Res (2012) 0.99

Identification of Merkel cell polyomavirus in the lower respiratory tract of Italian patients. J Med Virol (2010) 0.98

No causal association identified for human papillomavirus infections in lung cancer. Cancer Res (2014) 0.95

Human papillomavirus (HPV) and Merkel cell polyomavirus (MCPyV) in non small cell lung cancer. Exp Mol Pathol (2010) 0.94

Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer. Int J Cancer (2014) 0.92

Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. Int J Cancer (2013) 0.89

Merkel cell carcinoma and Merkel cell polyomavirus: evidence for hit-and-run oncogenesis. J Invest Dermatol (2011) 0.88

Identification of the novel KI Polyomavirus in paranasal and lung tissues. J Med Virol (2009) 0.87

Merkel cell polyomavirus in non-small cell lung carcinomas from Chile. Exp Mol Pathol (2012) 0.85

Lack of association between human papillomavirus type 16 and 18 infections and female lung cancer. Cancer Epidemiol Biomarkers Prev (2010) 0.85

No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study. Cancer Epidemiol Biomarkers Prev (2012) 0.81

Detection of KI polyomavirus and WU polyomavirus DNA by real-time polymerase chain reaction in nasopharyngeal swabs and in normal lung and lung adenocarcinoma tissues. Microbiol Immunol (2011) 0.79